13 Ventures - Unicorn Nest

13 Ventures

13 Ventures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Charlottesville

About

The main office of this VC is situated in Charlottesville. The fund is located in United States, North America.

Moreover, a start-up needs to be 2-3 years old to get investment from this fund. We can highlight the most popular investment areas for this fund, such as Biotechnology, Life Science. In addition, there are 2 more industries where it has achieved success. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. Palvella Therapeutics is among the most popular portfolio start-up of the fund.

The usual method for the fund is to invest in rounds with 2 other investors. The fund often co-invests with BioAdvance. The investor in the following rounds is usually Ligand Pharmaceuticals.

The fund generally invests in less than 2 deals every year. The fund's activity peaked in 2017.

The fund was established by Kevin Eisenfrats.

Fund Activity

Not operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together

BioAdvance

Funds Investing in Following
Rounds

Ligand Pharmaceuticals

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: